Like 2PY and 4PY, however, it is the product of the oxidizing conditions arising in renal failure, and its absence from erythrocytes of MoCo-deficient patients supports the mechanism involving aldehyde oxidase action on the nicotinamide riboside. This evidence concerns the gene AOX1 and acute kidney injury.